The Cooper Companies (COO), has recently been under the radar of many investment firms with its stock being repeatedly bought and sold. Following a Q1 earnings report that exceeded estimates, some firms such as Alecta Tjanstepension Omsesidigt and Dimensional Fund Advisors LP have purchased shares, while others like JPMorgan Chase & Co. and B. Metzler seel. Sohn & Co. AG have reduced their holdings. Despite a recent share price weakness drawing attention to the company's valuation, COO's Q1 earnings are expected to grow, gaining a 'moderate buy' rating from brokerages. Looking ahead, a potential trend reversal may be looming, with Needham raising its price target on the stock, suggesting this is a strong growth stock that's a notable long term investment. However, the stock has underperformed against the Dow and lost 8.8% in the past 4 weeks. Amid the trade volatility, insider buying and strategic portfolio management have signaled a rebound set up. With a recent guidance upgrade and positive price target adjustments, COO is asserting its resilience going forward in the bio-tech market.
The Cooper Companies COO News Analytics from Mon, 15 Sep 2025 07:00:00 GMT to Sat, 21 Mar 2026 06:31:48 GMT -
Rating 6
- Innovation 4
- Information 7
- Rumor -3
